Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

NCT03366766 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped slow accrual and lack of additional funding

Conditions

Non-Squamous Non-Small Cell Lung Carcinoma
Stage I Non-Small Cell Lung Cancer
Stage IA Non-Small Cell Lung Carcinoma
Stage IB Non-Small Cell Lung Carcinoma
Stage II Non-Small Cell Lung Cancer
Stage IIA Non-Small Cell Lung Carcinoma
Stage IIB Non-Small Cell Lung Carcinoma
Stage IIIA Non-Small Cell Lung Cancer

Interventions

BIOLOGICAL: Nivolumab
DRUG: Cisplatin
DRUG: Pemetrexed Disodium
DRUG: Gemcitabine Hydrochloride

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]